Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
FDA Orange Book
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Pursennid
2. Senna Glycoside
3. Sennoside A And B
4. Sennoside A And B, Calcium Salt
5. Sennoside A Calcium
6. Sennoside A Calcium And Sennoside B Calcium
7. Sennoside A+b Calcium
8. Sennoside A, Calcium Salt
9. Sennoside A, Calcium Salt (1:1)
10. Sennoside B Calcium
11. Sennoside B, Calcium Salt
12. Sennosides
13. Sennosides A And B
14. Sennosides A And B Acids
15. Senokot
1. Sennoside G
2. Pursennid (tn)
3. Sennosides (usp)
4. 66575-30-2
5. Senna-lax
6. Sennoside A&b
7. 9-[2-carboxy-4-hydroxy-10-oxo-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9h-anthracen-9-yl]-4-hydroxy-10-oxo-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9h-anthracene-2-carboxylic Acid
8. 517-43-1
9. Sennoside (jan)
10. Sennoside A1
11. Sennoside A1 , Hplc Grade
12. Schembl11140501
13. Chebi:34974
14. (9,9'-bianthracene)-2,2'-dicarboxylic Acid, 5,5'-bis(beta-d-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-, (r*,r*)-
15. Mfcd32068370
16. D02171
17. 135s582
18. Q27116343
19. [9,9'-bianthracene]-2,2'-dicarboxylic Acid, 5,5'-bis(.beta.-d-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-, (9r,9's)-
20. 5,5'-bis(beta-d-glucopyranosyloxy)-4,4'-dihydroxy-10,10'-dioxo-9,9',10,10'-tetrahydro-9,9'-bianthracene-2,2'-dicarboxylic Acid
21. 5,5'-bis(beta-d-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-9,9'-bianthracene-2,2'-dicarboxylic Acid
22. 9-[2-carboxy-4-hydroxy-10-oxo-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-9h-anthracen-9-yl]-4-hydroxy-10-oxo-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-9h-anthracene-2-carboxylic Acid
Molecular Weight | 862.7 g/mol |
---|---|
Molecular Formula | C42H38O20 |
XLogP3 | 1.2 |
Hydrogen Bond Donor Count | 12 |
Hydrogen Bond Acceptor Count | 20 |
Rotatable Bond Count | 9 |
Exact Mass | 862.19564360 g/mol |
Monoisotopic Mass | 862.19564360 g/mol |
Topological Polar Surface Area | 348 Ų |
Heavy Atom Count | 62 |
Formal Charge | 0 |
Complexity | 1550 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Laxatives
Agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve CONSTIPATION. (See all compounds classified as Laxatives.)
Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.
Registration Number : 227MF10003
Registrant's Address : 201,Empire Plaza,Mehrauli-Gurgaon Road Sultanpur,New Delhi-110 030,INDIA
Initial Date of Registration : 2015-01-05
Latest Date of Registration :
NDC Package Code : 55742-007
Start Marketing Date : 2012-05-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.
Registration Number : 225MF10137
Registrant's Address : 201,Empire Plaza,Mehrauli-Gurgaon Road Sultanpur,New Delhi-110 030,INDIA
Initial Date of Registration : 2013-07-23
Latest Date of Registration :
NDC Package Code : 55742-012
Start Marketing Date : 2012-05-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.
Registration Number : 219MF10246
Registrant's Address : 301,Avalon Apartments,Mehrauli-Gurgaon Road Manglapuri,New Delhi-110 030,INDIA
Initial Date of Registration : 2007-07-17
Latest Date of Registration :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32508
Submission : 2018-01-29
Status : Active
Type : II
NDC Package Code : 52537-001
Start Marketing Date : 2012-12-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32164
Submission : 2017-11-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13991
Submission : 1999-02-23
Status : Inactive
Type : II
NDC Package Code : 17353-0902
Start Marketing Date : 2013-09-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14132
Submission : 1999-05-01
Status : Inactive
Type : II
NDC Package Code : 17353-0903
Start Marketing Date : 2011-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29523
Submission : 2015-06-11
Status : Inactive
Type : II
Date of Issue : 2022-01-04
Valid Till : 2025-02-01
Written Confirmation Number : WC-0350
Address of the Firm :
NDC Package Code : 55977-802
Start Marketing Date : 2015-08-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
32
PharmaCompass offers a list of Sennoside A & B API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sennoside A & B manufacturer or Sennoside A & B supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sennoside A & B manufacturer or Sennoside A & B supplier.
PharmaCompass also assists you with knowing the Sennoside A & B API Price utilized in the formulation of products. Sennoside A & B API Price is not always fixed or binding as the Sennoside A & B Price is obtained through a variety of data sources. The Sennoside A & B Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sennoside A And B manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sennoside A And B, including repackagers and relabelers. The FDA regulates Sennoside A And B manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sennoside A And B API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sennoside A And B manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sennoside A And B supplier is an individual or a company that provides Sennoside A And B active pharmaceutical ingredient (API) or Sennoside A And B finished formulations upon request. The Sennoside A And B suppliers may include Sennoside A And B API manufacturers, exporters, distributors and traders.
click here to find a list of Sennoside A And B suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sennoside A And B DMF (Drug Master File) is a document detailing the whole manufacturing process of Sennoside A And B active pharmaceutical ingredient (API) in detail. Different forms of Sennoside A And B DMFs exist exist since differing nations have different regulations, such as Sennoside A And B USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sennoside A And B DMF submitted to regulatory agencies in the US is known as a USDMF. Sennoside A And B USDMF includes data on Sennoside A And B's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sennoside A And B USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sennoside A And B suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Sennoside A And B Drug Master File in Japan (Sennoside A And B JDMF) empowers Sennoside A And B API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Sennoside A And B JDMF during the approval evaluation for pharmaceutical products. At the time of Sennoside A And B JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Sennoside A And B suppliers with JDMF on PharmaCompass.
A Sennoside A And B written confirmation (Sennoside A And B WC) is an official document issued by a regulatory agency to a Sennoside A And B manufacturer, verifying that the manufacturing facility of a Sennoside A And B active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sennoside A And B APIs or Sennoside A And B finished pharmaceutical products to another nation, regulatory agencies frequently require a Sennoside A And B WC (written confirmation) as part of the regulatory process.
click here to find a list of Sennoside A And B suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sennoside A And B as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sennoside A And B API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sennoside A And B as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sennoside A And B and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sennoside A And B NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sennoside A And B suppliers with NDC on PharmaCompass.
Sennoside A And B Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sennoside A And B GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sennoside A And B GMP manufacturer or Sennoside A And B GMP API supplier for your needs.
A Sennoside A And B CoA (Certificate of Analysis) is a formal document that attests to Sennoside A And B's compliance with Sennoside A And B specifications and serves as a tool for batch-level quality control.
Sennoside A And B CoA mostly includes findings from lab analyses of a specific batch. For each Sennoside A And B CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sennoside A And B may be tested according to a variety of international standards, such as European Pharmacopoeia (Sennoside A And B EP), Sennoside A And B JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sennoside A And B USP).